Seeing Is Believing
Currently out of the existing stock ratings of Tom Roderick, 182 are a BUY (71.94%), 69 are a HOLD (27.27%), 2 are a SELL (0.79%).
Analyst Tom Roderick, currently employed at STIFEL, carries an average stock price target met ratio of 86.04% that have a potential upside of 19.92% achieved within 184 days.
Tom Roderick’s has documented 417 price targets and ratings displayed on 25 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on DOX, Amdocs Ltd at 02-Oct-2024.
Analyst best performing recommendations are on MDLA (MEDALLIA).
The best stock recommendation documented was for MDLA (MEDALLIA) at 7/22/2019. The price target of $43 was fulfilled within 4 days with a profit of $7 (19.44%) receiving and performance score of 48.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$625
$177.83 (39.77%)
$685
11 days ago
(12-Dec-2024)
3/7 (42.86%)
$146.85 (30.71%)
30
Buy
$620
$172.83 (38.65%)
$640
11 days ago
(12-Dec-2024)
13/19 (68.42%)
$141.85 (29.67%)
168
Hold
11 days ago
(12-Dec-2024)
4/4 (100%)
$32.49 (18.30%)
366
Buy
$600
$152.83 (34.18%)
$625
11 days ago
(12-Dec-2024)
11/16 (68.75%)
$121.85 (25.48%)
177
Hold
$525
$77.83 (17.41%)
$550
11 days ago
(12-Dec-2024)
10/13 (76.92%)
$46.85 (9.80%)
112
Which stock is Tom Roderick is most bullish on?
Which stock is Tom Roderick is most reserved on?
What Year was the first public recommendation made by Tom Roderick?